Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 20% ± 2% | |
| epithelial cell | 5 studies | 26% ± 5% | |
| macrophage | 5 studies | 18% ± 1% | |
| myeloid cell | 4 studies | 24% ± 10% | |
| astrocyte | 4 studies | 23% ± 8% | |
| non-classical monocyte | 3 studies | 21% ± 7% | |
| GABAergic neuron | 3 studies | 36% ± 9% | |
| glutamatergic neuron | 3 studies | 42% ± 11% | |
| dendritic cell | 3 studies | 22% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 4247.86 | 21 / 21 | 100% | 24.81 | 504 / 504 |
| breast | 100% | 4658.78 | 459 / 459 | 100% | 31.92 | 1118 / 1118 |
| esophagus | 100% | 4392.36 | 1445 / 1445 | 100% | 47.49 | 183 / 183 |
| intestine | 100% | 4626.08 | 966 / 966 | 100% | 22.21 | 527 / 527 |
| lung | 100% | 4466.70 | 578 / 578 | 100% | 38.42 | 1155 / 1155 |
| stomach | 100% | 3499.28 | 359 / 359 | 100% | 23.16 | 286 / 286 |
| uterus | 100% | 3799.15 | 170 / 170 | 100% | 33.39 | 459 / 459 |
| prostate | 100% | 3584.57 | 245 / 245 | 100% | 22.49 | 501 / 502 |
| skin | 100% | 7340.50 | 1809 / 1809 | 100% | 27.93 | 471 / 472 |
| liver | 100% | 2128.78 | 226 / 226 | 100% | 14.93 | 405 / 406 |
| kidney | 100% | 3080.10 | 89 / 89 | 100% | 24.97 | 897 / 901 |
| ovary | 100% | 3178.48 | 180 / 180 | 100% | 17.18 | 428 / 430 |
| thymus | 100% | 3643.38 | 653 / 653 | 100% | 19.55 | 602 / 605 |
| brain | 99% | 2632.41 | 2627 / 2642 | 100% | 27.64 | 705 / 705 |
| pancreas | 99% | 1944.38 | 324 / 328 | 99% | 23.37 | 176 / 178 |
| adrenal gland | 100% | 4766.29 | 258 / 258 | 97% | 14.34 | 224 / 230 |
| adipose | 100% | 5304.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4341.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 26.06 | 29 / 29 |
| muscle | 100% | 5702.73 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5609.86 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 43.99 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.17 | 1 / 1 |
| peripheral blood | 99% | 5699.05 | 918 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 14.36 | 79 / 80 |
| heart | 98% | 5253.69 | 847 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
| GO_0006657 | Biological process | CDP-choline pathway |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0042587 | Cellular component | glycogen granule |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0031210 | Molecular function | phosphatidylcholine binding |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0004105 | Molecular function | choline-phosphate cytidylyltransferase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0140678 | Molecular function | molecular function inhibitor activity |
| Gene name | PCYT1A |
| Protein name | Phosphate cytidylyltransferase 1A, choline Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A) choline-phosphate cytidylyltransferase (EC 2.7.7.15) |
| Synonyms | CTPCT PCYT1 |
| Description | FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis. . |
| Accessions | ENST00000411591.5 C9JVS0 ENST00000443555.1 ENST00000433733.5 C9JPY0 C9J050 ENST00000444822.5 C9J2E1 H7C1T3 ENST00000431016.6 ENST00000441879.5 C9JEJ2 ENST00000430755.5 P49585 F8WAZ5 F8WBU2 ENST00000292823.6 ENST00000419333.5 H7BZN1 ENST00000438634.5 ENST00000412869.5 |
